These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 3117609)

  • 1. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.
    Groop L; Luzi L; Melander A; Groop PH; Ratheiser K; Simonson DC; DeFronzo RA
    Diabetes; 1987 Nov; 36(11):1320-8. PubMed ID: 3117609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glyburide on in vivo insulin-mediated glucose disposal.
    Simonson DC
    Am J Med; 1990 Aug; 89(2A):44S-50S; discussion 51S-53S. PubMed ID: 2117389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of loss of first-phase insulin secretion on hepatic glucose production and tissue glucose disposal in humans.
    Luzi L; DeFronzo RA
    Am J Physiol; 1989 Aug; 257(2 Pt 1):E241-6. PubMed ID: 2669517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study.
    Groop LC; Ratheiser K; Luzi L; Melander A; Simonson DC; Petrides A; Bonadonna RC; Widén E; DeFronzo RA
    Acta Diabetol; 1991; 28(2):162-8. PubMed ID: 1777653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of glyburide on beta-cell sensitivity to glucose-dependent insulinotropic polypeptide.
    Meneilly GS; Bryer-Ash M; Elahi D
    Diabetes Care; 1993 Jan; 16(1):110-4. PubMed ID: 8422763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM.
    Rachman J; Gribble FM; Barrow BA; Levy JC; Buchanan KD; Turner RC
    Diabetes; 1996 Nov; 45(11):1524-30. PubMed ID: 8866556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of glipizide gastrointestinal therapeutic system on islet cell hormonal responses to a test meal in NIDDM.
    Mooradian AD; Albert SG; Bernbaum M; Plummer S
    Diabetes Care; 1996 Aug; 19(8):883-4. PubMed ID: 8842609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal hepatic insulin sensitivity in lean, mild noninsulin-dependent diabetic patients.
    Pigon J; Giacca A; Ostenson CG; Lam L; Vranic M; Efendic S
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3702-8. PubMed ID: 8855826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.
    Vaag A; Henriksen JE; Madsbad S; Holm N; Beck-Nielsen H
    J Clin Invest; 1995 Feb; 95(2):690-8. PubMed ID: 7860750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients.
    Simonson DC; Delprato S; Castellino P; Groop L; DeFronzo RA
    Diabetes; 1987 Feb; 36(2):136-46. PubMed ID: 3100365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.
    Mandarino LJ; Gerich JE
    Diabetes Care; 1984; 7 Suppl 1():89-99. PubMed ID: 6376034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.
    Groop L; Wåhlin-Boll E; Groop PH; Tötterman KJ; Melander A; Tolppanen EM; Fyhrqvist F
    Eur J Clin Pharmacol; 1985; 28(6):697-704. PubMed ID: 3933984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of pharmacokinetics, metabolic effects and mechanisms of action of glyburide and glipizide during long-term treatment.
    Groop L; Groop PH; Stenman S; Saloranta C; Tötterman KJ; Fyhrquist F; Melander A
    Diabetes Care; 1987; 10(6):671-8. PubMed ID: 3123184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glipizide on glucose metabolism and muscle content of the insulin-regulatable glucose transporter (GLUT 4) and glycogen synthase activity during hyperglycaemia in type 2 diabetic patients.
    Schmitz O; Lund S; Bak JF; Orskov L; Andersen PH; Møller N; Rasmussen O; Christiansen JS; Pedersen O
    Acta Diabetol; 1994 Apr; 31(1):31-6. PubMed ID: 8043894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
    Baron AD; Schaeffer L; Shragg P; Kolterman OG
    Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crossover comparison of maximum dose glyburide and glipizide.
    Simcic KJ; McDermott MT; White JC; Kidd GS
    South Med J; 1991 Jun; 84(6):743-6. PubMed ID: 1905060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of improvement in glucose metabolism after chronic glyburide therapy.
    Simonson DC; Ferrannini E; Bevilacqua S; Smith D; Barrett E; Carlson R; DeFronzo RA
    Diabetes; 1984 Sep; 33(9):838-45. PubMed ID: 6432610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.